Kenneth T. Mills resigns from Regenxbio board

Kenneth T. Mills resigned from the board of directors of Regenxbio (NASDAQ: RGNX), effective October 21, 2026, according to a company statement. Mills submitted his resignation on October 14, 2026, after becoming chief executive officer of another company.

The company stated that Mills' departure was not related to any disagreement with Regenxbio over its operations, policies, or practices.

Following Mills' exit, the board appointed George Migausky as Chairman of the Board. As Migausky is an independent director, Daniel Tassé stepped down from his role as Lead Independent Director in accordance with the company's Corporate Governance Guidelines, but will remain a board member.

You May Also Be Interested In

• Citi says Bank of Israel expected to hold rates steady next week
• ZentoAI signs MOU to acquire China-based digital tech firm
• Nano-X Imaging unit signs Italy distribution deal for bone health AI tool